Amicoat delivers next-generation antimicrobial technology for medical devices
Board of Directors
The Board of Directors represents the investors in Amicoat, and is comprised of representatives for the largest shareholders. The board brings expertise from the life science industry, finance, and corporate governance.
The Chairman of the Board represents North Murray, the private investment firm that is the largest shareholder in Amicoat.
Shareholders
Our leading shareholders bring invaluable expertise in life sciences and medical technology, aligning with our vision and guiding our progress.
Their extensive experience is directly leveraged through their active participation on our Board of Directors, where they hold crucial roles, including that of Chair and other board memberships.
Curious about investing in Amicoat, a leader in antimicrobial technology for medical devices?
Roger Tuen
Chief Executive Officer
Ola Skavlem
Chief Financial Officer
